Novel Peptide Compounds Show Promise as Ozempic Alternatives with Reduced GI Side Effects
Researchers have developed two new peptide compounds, GEP44 and KCEM1, that target weight loss with potentially fewer gastrointestinal side effects than current GLP-1 drugs.
Weight Loss Market Sees Rapid Growth with New Drugs and Supplements
The weight loss drugs market is predicted to grow rapidly, with analysts at SNS Insider forecasting a 43.73% CAGR through 2032, driven by rising obesity rates.
© Copyright 2025. All Rights Reserved by MedPath